Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCI-186 in Amyotrophic Lateral Sclerosis (ALS)
NCT01492686Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edaravone in amyotrophic lateral sclerosis (ALS), sponsored by Shionogi & Co., Ltd.. Started Dec 2011; status: completed.
02
Drugs
edaravone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01492686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01492686.